Moderna Competitors and Similar CompaniesClear all

CureVac's competitors and similar companies include Regulus Therapeutics, Celyad and Sarepta Therapeutics.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
Founding Date
Founding Date
2000
Founding Date
2007
Founding Date
2007
Founding Date
1980
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Locations
San Diego, US HQ
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Locations
Cambridge, US HQ
Dublin, IE
Zug, CH
Providence, US
Employees
Employees
999
Employees
2462% decrease
Employees
17
Employees
1,31413% increase
Valuation ($)
Valuation ($)
648.3 m
Valuation ($)
105.4 m
Valuation ($)
11.8 m
Valuation ($)
12.4 b

Financial

Revenue (est.)
Revenue (est.)
€53.8m (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
€102k (FY, 2023)
Revenue (est.)
$1.2b (FY, 2023)
Cost of goods
Cost of goods
€64.3m (FY, 2023)
Cost of goods
N/A
Cost of goods
€69k (FY, 2023)
Cost of goods
$150.3m (FY, 2023)
Gross profit
Gross profit
(€2.6m) (FY, 2023)
Gross profit
N/A
Gross profit
€1.4m (FY, 2023)
Gross profit
$1.1b (FY, 2023)
Net income
Net income
(€260.2m) (FY, 2023)
Net income
($30m) (FY, 2023)
Net income
(€8.4m) (FY, 2023)
Net income
($536m) (FY, 2023)

Operating

Patents Issued
Patents Issued
233 (May, 2020)
Patents Issued
300 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
$ 1.1b
Total funding raised
$ 10m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company
Celyad
HQ
Mont-Saint-Guibert, BE
Employees
17

Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.

View company
Sarepta Therapeutics
HQ
Cambridge, US
Employees
1,314↑ 13% increase

Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.

View company